The human leukemic T cell line Jurkat is widely used as a model system to study intracellular signaling cascades during lymphocyte activation. These studies have revealed the critical requirement for two signaling pathways to complete lymphocyte activation. In the first pathway, activation of protein kinase C, particularly protein kinase C, leads to the phosphorylation of several cytoplasmic proteins and the triggering of transcription via the assembly of the Fos/Jun transcription factor complex on AP1 elements in several genes (1) (2) (3) (4) . In the second cascade, the sustained entry of Ca 2ϩ from the external milieu raises the cytoplasmic Ca 2ϩ concentration, leading to gene transcription mediated by the nuclear factor of activated T cells (NF-AT) 1 (5, 6) . Production of the key T cell cytokine IL-2 requires the simultaneous activation of both pathways, with Ca 2ϩ being absolutely required for the process.
In human T lymphocytes and in Jurkat T cells, Ca 2ϩ influx is mediated by the opening of voltage-independent Ca 2ϩ release-activated Ca 2ϩ (CRAC) channels (7) (8) (9) . Movement of ions through open channels in the plasma membrane is driven by an electrochemical gradient. Upon T cell stimulation and opening of CRAC channels, the electrochemical gradient supporting Ca 2ϩ entry is large, resulting in significant Ca 2ϩ influx. However, Ca 2ϩ entry could result in depolarization of the plasma membrane, limiting further influx. Therefore, to maintain Ca 2ϩ entry over the time scale required for gene transcription, a balancing cation efflux is necessary. Efflux of K ϩ ions through K ϩ channels is thought to provide the electrochemical driving force for Ca 2ϩ entry via regulation of membrane potential (10) . We have directly tested this idea and identified the functionally important K ϩ channel subtypes in Jurkat T cells and activated normal human T cells.
Jurkat T cells express two distinct K ϩ channels. The first is a voltage-gated K ϩ (K V ) channel encoded by the Kv1.3 gene, and the second is a small conductance Ca 2ϩ -activated K ϩ (K Ca ) channel recently shown to be encoded by the hSKCa2 gene (11) (12) (13) (14) . Human T cells possess a different K Ca channel encoded by hIKCa1, in addition to Kv1.3, but do not express SKCa2 (15) (16) (17) (18) . Earlier work investigating the roles of K ϩ channels in lymphocyte activation was hampered by the lack of sufficiently specific blockers, leading to conflicting results and divergent interpretations (see, for example, Refs. 19 and 20) . Expression levels of K V and K Ca channels are similar in Jurkat and in mitogen-activated human T cells, although the molecular identity of the K Ca channel differs in these two cell types (15) . This difference in expression pattern, the advent of new and highly specific blockers of all three channels, and the potential for genetic manipulation of functional expression levels provide an opportunity to examine the contributions of K ϩ channels in regulating membrane potential and Ca 2ϩ signaling in lymphocytes. Our results emphasize the importance of K Ca channels in the modulation of Ca 2ϩ signaling.
EXPERIMENTAL PROCEDURES
Cell Culture and Chemicals--Jurkat E6 -1 and COS-7 cells were obtained from ATCC (Manassas, VA). Jurkat E6 -1 cells were grown in RPMI medium supplemented with 10% fetal bovine serum, 2 mM glutamine, and 10 mM HEPES at densities of 1-9 ϫ 10 5 in a 37°C humidified incubator with 5% CO 2 . COS-7 cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum and 2 mM glutamine and split twice weekly. Human T cells were isolated and cultured as described (21) . T cells were preactivated by addition of 4 g/ml * This work was supported by National Institutes of Health Grants NS14609 and GM41514 (to M. D. C.), National Institutes of Health Grants MH59222 and GM54221 (to K. G. C.), a Feodor Lynen fellowship from the Alexander von Humboldt Foundation (to H. R.), and Deutsche Forschungsgemeinschaft Fellowship Grant WU 320/1-1 and Western States Affiliate of the American Heart Association Grant 9920014Y (to H. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Transfection of Constructs into Mammalian Cells-In each electroporation cuvette (gap of 0.4 cm), 10 7 Jurkat cells and 10 g of the DNA of interest were electroporated at 960 F, 250 V, and then resuspended in 15 ml of fresh culture medium and returned to the incubator for 36 -60 h prior to use. COS-7 cells (5 ϫ 10 5 cells/chamber) were plated in culture chambers and transiently transfected using the Lipofectin transfection reagent (Life Technologies, Inc.) with the DNA of interest following the manufacturer's recommended protocol in OptiMEM medium (Life Technologies, Inc.). Following an 8 -12-h transfection, the cells were placed in fresh growth medium in the incubator for 48 h. Typical transfection efficiencies using this protocol were 18 -33%. The DNA vectors used for transfection were prepared using the Qiagen (Valencia, CA) endotoxin-free plasmid maxi-prep kit.
DNA Constructs-The N-terminal GFP fusion protein of human IKCa1 (GFP-IKCa1) was a gift from J. Aiyar (AstraZeneca Pharmaceuticals, Wilmington, DE) and was generated by subcloning hIKCa1 into the pEGFP-C1 vector (CLONTECH, Palo Alto, CA) as a BamHI/BglIIXho fragment. This cloning strategy introduced 12 extra amino acids between GFP and the initiation codon of IKCa1. The expressed sequence tag clone IMAGE: 2248 (GenBank TM accession number AI810558), corresponding to nucleotides 491-2193 of the SKCa2 sequence AF239613, was isolated from the pT7T3 Pac Vector (Amersham Pharmacia Biotech) using NotI and EcoRI restriction sites and subcloned into pBluescript and from there into the SacI restriction site of the pGFP-C1 expression vector. The truncated hSKCa2 dominant negative construct was generated by removing a 1.24-kilobase pair BclI fragment from the GFP-SKCa2 construct, leaving a 564-base pair insert encoding the hSKCa2 N-terminal proximal region terminating in the S3 transmembrane domain. The human SKCa3 clone (GenBank TM accession number AJ251016) containing 19 polyglutamines in the N terminus was cloned in frame to GFP in the GFP vector as an EcoRI/ BamI fragment. HEK-293 cells expressing the skeletal muscle sodium channel hSKM1 (SCN4A) were a gift from Dr. F. Lehmann-Horn (University of Ulm, Germany) (26) . The murine Kv1.3 channel is stably expressed in L929 cells as previously described (12) . The hSlo construct was the gift of Dr. Ligia Toro (University of California, Los Angeles, CA) and is expressed following injection into Xenopus oocytes (27, 28) .
Patch Clamp Experiments-For all K Ca experiments, electrophysiological recordings were made in the whole-cell mode with a holding potential of -40 mV and an internal solution consisting of 130 mM potassium aspartate, 10 mM K 2 EGTA, 8.55 mM CaCl 2 , 2.08 mM MgCl 2 , and 10 mM HEPES, pH 7.2, with a calculated free [Ca 2ϩ ] of ϳ1 M. In K V experiments, whole-cell recordings were made with a holding potential of -80 mV and an internal solution identical except that it contained 2.28 mM CaCl 2 , resulting in a calculated free [Ca 2ϩ ] of ϳ50 nM. K V experiments also used a leak subtraction regimen in which the leak pulse was applied after each voltage pulse. External solutions consisted of normal Ringer solution (155 mM NaCl, 4.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM D-glucose, and 5 mM HEPES, pH 7.4), K ϩ Ringer solution (with identical ingredients except that all NaCl was substituted by KCl, resulting in a final KCl concentration of 159.5 mM), or 40 mM K ϩ Ringer solution, in which these two solutions were mixed to yield a final Na ϩ concentration of 119.5 mM and a final K ϩ concentration of 40 mM. Whole-cell patch clamp recordings were performed using the equipment and techniques described previously, and all data were corrected for a liquid junction potential of Ϫ13mV for aspartate-based solutions (29) .
Cytokine Expression Assays-Jurkat cells were stimulated as described above for T cells but in 96-well tissue culture plates with 10 5 cells in 200 l of growth medium. Cytokine production was assayed using the OptEIA enzyme-linked immunosorbent assay kit (BD-Pharmingen, San Diego, CA) and a fluorescence plate reader (Molecular Devices, Sunnyvale, CA) to quantify production of IL-2 and IL-8.
Confocal Microscopy-Confocal fluorescence images were taken with a Bio-Rad MRC-600 equipped with an argon laser (488 nm) and a fluorescein isothiocyanate filter set (500 -530 nm). All images were acquired under a 63ϫ oil objective on a Zeiss Axiovert 35 microscope. Z-series sections were captured at 0.5-m intervals, and optical section thickness was estimated to be ϳ0.45-m. Ca 2ϩ Imaging and Membrane Potential Measurements-Cells were loaded in 1 M fura-2/AM ester (Molecular Probes, Eugene, OR) at 21-24°C for 30 min, washed, and stored in the dark until use (within 3 h). Intracellular Ca 2ϩ concentrations were estimated, and experiments were performed utilizing a complete video microscopic, ratiometric Ca 2ϩ imaging system (Videoprobe, ETM Systems), as previously described (30) . At the beginning of data collection, the extracellular solution was normal Ringer solution. Store depletion in the presence of Tg required perfusion with a 0-Ca 2ϩ version of normal Ringer solution in which CaCl 2 was replaced by additional MgCl 2 to keep divalent concentrations constant and in which 1 mM EGTA was used to chelate residual Ca 2ϩ . During measurements on transfected cells, individual GFP-positive, and thus successfully transfected, cells were identified and marked for analysis using a fluorescein isothiocyanate filter set consisting of a 480 Ϯ 20 nm exciter, 505 nm dichroic mirror, and 520 nm long-pass emission filter. By comparing Ca 2ϩ responses of GFPhSKCa2⌬-expressing or GFP-hIKCa1-expressing cells with GFP-expressing vector control cells, we eliminated the risk of inaccurate quantification due to small amounts of contamination of the fura-2 signal by GFP fluorescence bleed-through. Data processing and statistical analysis were carried out using IgorPRO (Wavemetrics, Lake Oswego, OR) and Excel (Microsoft, Redmond, WA) software. The bis-oxonol dye bis-(1, 3-dibutylbarbituric acid)trimethine oxonol (DiBAC4(3), Molecular Probes) was used as an indicator of membrane potential in imaging experiments using the same software and hardware described for Ca 2ϩ imaging, and using the fluorescein, filter set described above. Cells were preequilibrated with 125 nM DiBAC4(3) for 5-10 min prior to the start of each experiment, and dye concentration was maintained in all external solutions throughout the experiment.
RESULTS

Specific K ϩ Channel Blockers Define the Role of K V and K Ca Channels in Jurkat Ca
2ϩ Signaling-Using the patch clamp technique, we characterized highly potent and specific K Ca and K V channel blockers in Jurkat T cells and activated human T lymphocytes. In Jurkat cells, whole-cell recording with Ca 2ϩ maintained at a low concentration inside the pipette revealed only K V currents (Fig. 1A) . These currents inactivated during repetitive pulsing and were blocked by ShK-Dap 22 , a sea anemone peptide modified to gain specificity for the Kv1.3 channel (IC 50 ϭ ϳ25 pM) (31) . Application of 10 nM ShK-Dap 22 blocked ϳ97% of the K V current. The voltage dependence, inactivation kinetics, and pharmacological properties of Jurkat K V currents are consistent with Kv1.3 encoding this channel, as reported previously (32) .
Elevation of [Ca 2ϩ ] inside the pipette to 1 M activated an additional small, voltage-independent current. By increasing extracellular K ϩ concentrations to 40 mM, the inward component of this current could be observed. The current reversed near the predicted Nernst potential for a K ϩ -selective current in 40 mM K ϩ extracellular solution (Fig. 1B) . Application of 10 nM apamin, a peptide from bee venom, completely and irreversibly blocked this K Ca current (data not shown), in agreement with a previous study (11) , whereas Kv1.3 blockers ShK-Dap 22 (250 nM, Fig. 1B ) and charybdotoxin (10 nM, data not shown) had little or no effect. Recently, a group of bis-quinolinium derivatives developed by the group of C. R. Ganellin and D. H. Jenkinson at University College London were found to block with high affinity the apamin-sensitive small conductance K Ca channel in rat superior cervical ganglion cells (33) . We tested these same compounds on the apamin-sensitive K Ca current in Jurkat T cells. The bis-quinolinium cyclophane UCL 1684 (see under "Experimental Procedures" for full name) at a concentration of 10 nM blocked 95 Ϯ 5% of the K Ca current but had no effect on the K V current even at 250 nM (Fig. 1, A and B) . Blocking was rapid (usually complete within 1 min) and, in contrast to apamin, rapidly reversible. The dose-response curve in Fig. 1D shows that UCL 1684 blocks the Jurkat K Ca channel with subnanomolar affinity (IC 50 ϭ 180 pM), making it the most potent inhibitor of this channel yet described. The molecular identity of the K Ca channel in Jurkat T cells was verified by measuring the efficacy of UCL 1684 in blocking current through the cloned human SKCa2 and SKCa3 channels expressed in COS-7 cells (IC 50 values of 280 pM and 9.5 nM, respectively). UCL 1684 selectively blocks Jurkat K Ca channels and SKCa2 channels over the closely related SKCa3 channel and several other more distantly related channels ( Fig. 1D ; Table I ). Other bis-quinolinium cyclophanes (UCL 2079, UCL 1848, and UCL 1530; see under "Experimental Procedures" for full names) also blocked Jurkat K Ca currents with high affinity (Fig. 1C) . Table I summarizes the selectivity of all compounds and demonstrates that UCL 1684, UCL 1848, and UCL 2079 are all ϳ10 4 -fold more effective at blocking SKCa currents than any other channels tested. Because these drugs are highly specific for the K Ca channel found in Jurkat T cells and appear equally potent in blocking the expressed human SKCa2 channel, our results provide a confirmation that the SKCa2 gene encodes the K Ca channel in Jurkat T cells (13, 14) .
We used a pharmacological approach to discern the contributions of Kv1.3 and SKCa2 channels to calcium signaling in Jurkat T-cells. Ca 2ϩ signaling can be induced by thapsigargin (Tg), a specific inhibitor of the sarco-endoplasmic reticulum Ca 2ϩ ATPase that enables study of Ca 2ϩ entry independent of Ca 2ϩ release from internal stores (34) . Depletion of intracellular Ca 2ϩ stores with Tg in the absence of extracellular Ca 2ϩ activates CRAC channels in the plasma membrane, permitting Ca 2ϩ entry upon reintroduction (35) . In Jurkat T cells, the K Ca channel inhibitor UCL 1684 reduced Ca 2ϩ influx, but not the Tg-induced release of intracellular Ca 2ϩ stores ( Fig. 2A) , in a dose-dependent manner that closely paralleled the dose-dependent block of the native K Ca current (Fig. 2B) . Maximal inhibition of the [Ca 2ϩ ] i plateau was achieved at 10 nM UCL 1684, a dosage that blocked 95 Ϯ 5% of Jurkat K Ca channels. This dosage of UCL 1684 had no effect on IL-2 production in Jurkat cells but inhibited IL-8 production by 30% (data not shown). In contrast, application of the Kv1.3 blocker ShKDap 22 (up to 10 nM) did not affect the Ca 2ϩ response or cytokine production ( Fig. 2A and data not shown) . These results demonstrate that K Ca channels but not K V channels help maintain Jurkat cell Ca 2ϩ entry. The most likely mechanism by which UCL 1684 inhibits Ca 2ϩ entry is depolarization of the membrane potential resulting from Ca 2ϩ entry through CRAC channels in the absence of K Ca channel function. To test this possibility, the membrane potential of Jurkat T cells was monitored using a voltagesensitive dye during the same Tg stimulation protocol used in Fig caused a moderate depolarization of most cells, followed by a marked hyperpolarization upon Ca 2ϩ readdition (Fig. 2C, solid  line) . This hyperpolarization must be caused by the opening of SKCa2 channels because cells treated with UCL 1684 instead showed profound membrane depolarization following Ca 2ϩ reintroduction (Fig. 2C, dotted line) . Similar results were observed in perforated-patch current clamp recordings (data not shown). These results demonstrate the tight link between K Ca channel opening, modulation of membrane potential, and regulation of Ca 2ϩ entry. The Role of K Ca Channels in Activated Normal Human T Cells-Activated human T cells present an excellent system to further test the role of K Ca channels in Ca 2ϩ regulation. Mitogen-activated human T cells and Jurkat cells express similar numbers of K V and K Ca channels, suggesting that they may regulate calcium signaling in a similar manner. The K V channel in human lymphocytes and in Jurkat T cells is encoded by the Kv1.3 gene (32, 36) . However, the K Ca channel in human T cells is the product of the IKCa1 gene that is phylogenetically related to the SKCa2 gene found in Jurkat cells. Both K Ca channels share a common calmodulin-dependent mechanism for calcium-dependent gating (29, 37, 38) , and both exhibit a conserved genomic organization (39) .
To test whether IKCa1 and SKCa2 serve similar functions in sustaining Ca 2ϩ signaling, we used agents that are selective for the block of the K Ca channels found in mitogen-activated human T cells, including the charybdotoxin mutant ChTX-Glu 32 and the clotrimazole analogue TRAM-34 (28, 40) . We first verified that these blockers are selective for IKCa1 by testing them on this channel in an expressed system. As shown in Fig.  3A , IKCa1 channels are blocked by ChTX-Glu 32 (IC 50 ϭ ϳ30 nM) (28) . Neither the UCL compounds (10 nM) nor ShK-Dap 22 (250 nM) affected the IKCa1 channel (Fig. 3A and data not  shown) . The triarylmethane blocker of IKCa1, TRAM-34 (IC 50 ϭ ϳ20 nM), also blocks native or expressed IKCa1 current with high selectivity (data not shown) (40) .
Tg-induced Ca 2ϩ responses in human T cells activated for 48 h with anti-CD3 antibody are partially suppressed by the IKCa1-specific inhibitors ChTX-Glu 32 and TRAM-34, as shown in Fig. 3B , whereas UCL 1684 (10 nM, Fig. 3C ) had little effect. Note that the absence of any effect of UCL 1684 on Ca 2ϩ influx in T cells argues that CRAC channels, too, are unaffected by this drug, because CRAC currents in human T cells and Jurkat cells are identical (8, 9) . In parallel with the inhibition of Ca 2ϩ influx in activated T lymphocytes achieved by the IKCa1 blockers, TRAM-34 was previously reported to suppress proliferation of activated T-cells far more effectively than resting T cells (39, 40) . In contrast, the Kv1.3 blocker ShK-Dap 22 (500 nM, Fig.  3D ) did not inhibit Ca 2ϩ influx in activated T cells (Fig. 3D) , consistent with an earlier report that Kv1.3 blockade does not suppress proliferation of activated cells (39) . Taken together with the data on Jurkat cells, these results further emphasize the role of K Ca channels in cells of the immune system. Dominant-negative Knockout Strategy-To verify that UCL 1684 reduces Ca 2ϩ entry in Jurkat cells by specific inhibition of the K Ca channel, we used a dominant-negative suppression strategy to prevent K Ca expression. A functional Jurkat K Ca channel is expected to be a homotetramer of the SKCa2 protein.
In K V channels, tetramerization is partly determined by the N-terminal T1 domain, and overexpression of N-terminal fragments containing the T1 domain results in dominant-negative suppression of native channels via co-assembly of the truncated fragments with native subunits in nonfunctional tetramers (41) . Hypothesizing that the N termini of K Ca channels contain a similar tetramerization domain, we transfected COS-7 cells and Jurkat T-cells with a GFP-tagged N-terminal fragment of the human SKCa2 gene (GFP-hSKCa2⌬). Confocal microscopy of transfected COS-7 cells revealed mainly endoplasmic reticulum localization of GFP-hSKCa2⌬ (Fig. 4A) ; similar results were obtained with the smaller Jurkat cells (data not shown). Parallel patch clamp experiments were performed in controltransfected and GFP-hSKCa2⌬-transfected Jurkat cells. Expression of the GFP-hSKCa2⌬ construct abolished whole-cell K Ca current in Jurkat cells (Fig. 4C) , compared with vectortransfected control cells (Fig. 4B) . Interestingly, the hSKCa3 N-terminal fragment also suppressed this current (data not shown), suggesting that these two channels can heteromultimerize, as has been reported for SKCa2 and SKCa1 (42) . These results strongly suggest that SKCa channels, like K V channels, contain a tetramerization domain in the N terminus. The GFPhSKCa2⌬ cells were used to test the role of the K Ca channel in Ca 2ϩ signaling. Cells expressing the dominant-negative GFPhSKCa2⌬ construct exhibited significantly attenuated Ca 2ϩ entry (Fig. 4D, dotted line) compared with vector-control cells, reinforcing the conclusion that functional activity of the K Ca channel sustains normal Ca 2ϩ signals in Jurkat cells. The decreased level of Tg-induced store release in cells expressing the GFP-hSKCa2⌬ construct could in principle result from inhibited release of Ca 2ϩ stores or from a smaller total store content. By perfusing ionomycin (4 M) following depletion of stores with Tg, we found that GFP-hSKCa2⌬-expressing cells have a larger Tg-nonreleasable store content than vector-control cells (data not shown), suggesting that functional hSKCa2 could be related to store release in an unknown manner.
Recently, it was observed that treatment with the mitogenic lectin phytohemagglutinin decreases the number of SKCa2 channels expressed in Jurkat cells (14) . Corresponding to this decrease, we find that Tg-induced Ca 2ϩ influx is reduced by ϳ50% in Jurkat cells activated with phytohemagglutinin for 48 h (data not shown), consistent with the suppression of Ca 2ϩ signaling by pharmacological blockade of K Ca channels (Figs. 2  and 3 ) and by knocking out native SKCa2 expression using a dominant-negative construct (Fig. 4) .
Compensation with a UCL 1684-resistant K Ca Channel, IKCa1-We next tested whether the UCL 1684-resistant intermediate conductance K Ca channel, hIKCa1, present in activated human T cells, can effectively substitute for the Jurkat SKCa2 channel. Transfection with GFP-tagged hIKCa1 (GFPhIKCa1) led to endoplasmic reticulum and plasma membrane staining of COS-7 and Jurkat cells (Fig. 5A ) and conferred expression of large K Ca currents in both cell types (data not shown). Jurkat cells transfected with IKCa1 expressed wholecell K Ca currents Ͼ100 times larger than those observed in cells transfected with vector alone (Fig. 5B) . These currents were Ca 2ϩ -activated, insensitive to UCL 1684, and blocked by the IKCa1-selective peptide ChTX-Glu 32 ( Fig. 5B ) (28), demonstrating that the overexpressed GFP-tagged hIKCa1 channel functions as expected. Cells overexpressing hIKCa1 were rescued from pharmacological inhibition of Ca 2ϩ influx by UCL 1684 (Fig. 5C) . Thus, the hIKCa1 channel can substitute for the native SKCa2 channel in Jurkat cells and effectively sustains the Ca 2ϩ response.
DISCUSSION
Using three independent strategies, we demonstrate a critical role for K Ca channels, but not K V channels, in regulating the Ca 2ϩ signaling response in T lymphocytes. First, we used se- lective and potent blockers of K V and K Ca channels provided by a series of bis-quinolinium compounds, a modified peptide from sea anemone toxin, and a scorpion toxin mutant peptide to inhibit SKCa2, Kv1.3 and IKCa1, respectively. In Jurkat T cells, the bis-quinolinium cyclophane UCL 1684 inhibited Ca 2ϩ influx with a potency that mirrored its dose-response curve for block of SKCa2 current (Figs. 1 and 2 and Table I ), whereas selective blockade of Kv1.3 had little or no effect. Furthermore, in activated T cells, blockade of the native IKCa1 channel with the selective and potent inhibitors, ChTX-Glu 32 and TRAM-34, significantly suppressed Ca 2ϩ influx, whereas UCL 1684 had no effect in these cells, and Kv1.3 blockers again were ineffective (Fig. 3) . Second, dominant negative suppression of SKCa2 channel expression in Jurkat cells effectively inhibited Ca 2ϩ entry, confirming the functional importance of these channels by a completely independent experimental approach (Fig. 4) . Third, overexpression of the pharmacologically distinct K Ca channel, hIKCa1, in Jurkat T cells rescued Ca 2ϩ entry from inhibition by UCL 1684 (Fig. 5) . Thus, using a pharmacological strategy based on selective blockade of each channel in conjunction with molecular approaches to vary expression levels, we demonstrate that the SKCa2 channel in Jurkat T cells and the IKCa1 channel in human T cells sustain Ca 2ϩ signaling. Antigen-dependent activation of T lymphocytes increases cytoplasmic Ca 2ϩ to micromolar levels. During periods of Ca 2ϩ entry through CRAC channels, T lymphocytes could become depolarized because of the inward current carried by Ca 2ϩ ions. This in turn would lead to the dissipation of the electrochemical gradient required for continued Ca 2ϩ entry. In resting human T cells that express ϳ400 Kv1.3 channels along with only ϳ10 IKCa1 channels and ϳ10 CRAC channels (9) , the K V channels should be sufficient to compensate for transient depolarization by opening to allow K ϩ efflux, resulting in repolarization of the cell. Indeed, high K ϩ extracellular solution or blockade of these channels by ChTX, correolide, ShK-Dap 22 , or organic antagonists such as progesterone suppresses mitogenesis and IL-2 production (20, 39, (43) (44) (45) (46) . In each case, depolarization of the membrane potential resulting from K ϩ channel block or manipulation of K ϩ gradients limits Ca 2ϩ entry. The situation is significantly different in Jurkat T cells and in previously activated human T lymphocytes, both containing roughly equivalent numbers of K Ca (ϳ300 -500/cell) and K V (300 -600/cell) channels (10) . It is likely that the increased number of CRAC channels in these cells (ϳ100 -300/cell) (9) overpowers the ability of Kv1.3 channels to maintain membrane potential, as evidenced by the fact that K V channel blockers can no longer suppress proliferation (38, 39) . The up-regulation of K Ca channel expression during T cell activation is sufficient to compensate for increased Ca 2ϩ influx, because T cells have been observed to hyperpolarize during sustained Ca 2ϩ signaling (47) . Conversely, T cells depolarize during blockade of K Ca channels, resulting in reduced Ca 2ϩ entry and emphasizing the importance of K Ca channels in maintaining the membrane potential (Fig. 2, A and C) (48, 49) . This interplay between channel activation and changes in the membrane potential is likely to result in the repeated depolarization and repolarization that contributes to oscillatory Ca 2ϩ entry (21, 50, 51) .
Are the roles of the different K Ca channels found in T lymphocytes and in Jurkat cells interchangeable? Both channels are activated by the same mechanism, the binding of Ca 2ϩ to calmodulin preassociated with the cytoplasmic C terminus of the channel (29, 37, 38) . Both open in response to small changes in intracellular Ca 2ϩ concentrations, providing the counterbalancing cation efflux and maintaining the membrane potential required for long lasting Ca 2ϩ entry. Indeed, IKCa1 can effectively substitute for blocked Jurkat SKCa2 (Fig. 5) . Thus, the K Ca channels in Jurkat cells (SKCa2) and in activated human T lymphocytes (IKCa1) seem to play identical roles in Jurkat T cells and in activated T lymphocytes. The sustained Ca 2ϩ response of T lymphocytes is necessary for maintenance of nuclear factor of activated T cells in the nucleus and for numerous other events in T cell activation (4, 6) . We are now beginning to understand the critical role played by K Ca channels in this signaling cascade. In human T cells, K Ca channel blockers prevent T cell proliferation and may become therapeutically useful (38, 40, 52) . In Jurkat cells, selective inhibition by UCL 1684 of IL-8 production over IL-2 production (see under "Results") hints that reduction of Ca 2ϩ entry may have complex effects on cytokine gene expression. Indeed, the reduced Ca 2ϩ entry observed in Th2 cells compared with Th1 cells results in part from the lower level of K Ca channel expression in Th2 cells (30) . Future work should help to clarify the role that these channels play in cytokine expression and in determining the cytokine profile of T cells during differentiation.
